Revolutionizing Healthcare: Microbot Medical Speeds Up Patient Enrollment for Groundbreaking Clinical Trial, Exceeding Expectations with 80% of Participants Already Completing Follow-Up

Revolutionizing Healthcare: Microbot Medical Speeds Up Patient Enrollment for Groundbreaking Clinical Trial Exceeding Expectations with 80% of Participants Already Completing Follow-Up Confirms the Company on Track for FDA 510(k) Submission by end of 2024 Completes All IDE required Tests and Receives Final IDE Approval from the FDA for the ACCESS-PVI Study BRAINTREE, Mass., Sept. 30,…

Read More

Revolutionizing Real Estate in Dubai: Blackwell 3D Partners with Asas Capital to Secure Funding for Upcoming Projects

Welcome to the Future of Real Estate: Blackwell 3D Construction Corp. Partners with Asas Capital DUBAI, UAE, Sept. 30, 2024 (GLOBE NEWSWIRE) Blackwell 3D Construction Corp. (OTC: BDCC) (“Blackwell 3D” or the “Company”), an innovative 3D house printing technology company, is pleased to announce that it has engaged Asas Capital, a boutique investment advisory firm,…

Read More

Big News Alert: NeuroBo Pharmaceuticals Crushes Obesity Study! Get the Scoop on Their Exciting Phase 1 Results

Data Revealed Favorable Safety, Tolerability and Dose-Linear Pharmacokinetics (PK) Top-Line Data Exciting News from NeuroBo Pharmaceuticals, Inc. Cambridge, Mass., Sept. 30, 2024 NeuroBo Pharmaceuticals, Inc. has just announced some exciting news that has the medical world buzzing with anticipation. The clinical-stage biotechnology company has shared positive top-line safety, tolerability, and dose-linear pharmacokinetics (PK) data from…

Read More

Unlocking Potential: TAFE’s Letter to AGCO Shareholders on Elevating Corporate Governance and Maximizing Value Creation

TAFE Issues Open Letter to AGCO Shareholders Introduction CHENNAI, India–(BUSINESS WIRE)–Tractors and Farm Equipment Limited (TAFE) is the largest shareholder of AGCO Corporation with a 16.3% long-term strategic ownership interest in the Company. TAFE recently issued an open letter to its fellow shareholders, outlining their position and vision for the future. The Open Letter Fellow…

Read More

Reflecting on Success: InMed Pharmaceuticals’ Fiscal Year 2024 Financial Results and Exciting Business Update

Exciting Developments in Pharmaceutical Research INM-901: A Promising Advancement in Alzheimer’s Disease Treatment Recent news from InMed Pharmaceuticals Inc. has unveiled exciting progress in their INM-901 program, which targets several biological pathways associated with Alzheimer’s disease. This development is a significant step forward in the ongoing battle against this debilitating condition, offering hope to millions…

Read More

Analyst Predicts 5x Surge for Solana by Q4 2025: Why This Cryptocurrency Has the Best Shot at Success

The Future of Solana: A Closer Look at the Predicted Price Surge What Happened A prominent cryptocurrency commentator, MartyParty, recently made a bold prediction regarding the future price of Solana (CRYPTO: SOL). In a post shared on Sunday, MartyParty suggested that Solana could experience a significant price surge, potentially offering investors up to a 5x…

Read More

Tinley’s Launches Hemp Delta-9 THC-Infused Beckett’s Tonics at Total Wine & More

The Tinley Beverage Company Inc. Announces First Production Run of Beckett’s Hemp-Derived Delta-9 THC-Infused Tonics Toronto, Ontario and Los Angeles, California–(Newsfile Corp. – September 30, 2024) The Tinley Beverage Company Inc. (CSE: TNY) (OTCQB: TNYBF) (“Tinley’s” or the “Company”) announces that its first production run of Beckett’s hemp-derived Delta-9 THC-infused (“HD9”) versions of its classic…

Read More